Aptamer-Based Screening and Detection of Serum Biomarkers for Lung Cancer
Preprint
- 3 November 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Lung cancer remains the leading cause of cancer death worldwide, and most patients are still diagnosed after symptoms appear, when curative treatment is no longer possible. Low-dose computed tomography (LDCT) reduces mortality in high-risk smokers, yet uptake is low, eligibility criteria exclude the large never-smoker populations of East Asia, and false-positive findings generate downstream harm. A blood test that could triage who needs imaging, or rule out disease in indeterminate nodules, would therefore have substantial clinical value. Aptamers - short single-stranded oligonucleotides selected in vitro and produced by chemical synthesis - are attractive as the recognition layer of such a test because they can be generated against native membrane proteins and glycans, are thermostable and can be labelled site-specifically at low cost. Here we review the serum biomarker landscape in lung cancer, the chemistry that makes aptamers usable in serum, the selection strategies that now deliver picomolar binders within days, and the transduction architectures that convert binding into a clinical readout. We argue that analytical sensitivity is no longer the limiting factor: the field’s bottleneck has moved upstream to matrix-adapted affinity and downstream to prospective, blinded validation.Keywords
All Related Versions
This publication has 63 references indexed in Scilit:
- Sensitive chemiluminescent determination of CYFRA 21–1 as a lung cancer marker using PVP/NiO-supported luminol@ZIF-67-aptamer compositeMicrochimica Acta, 2025
- From cell-SELEX to tissue-SELEX for targeted drug delivery and aptamer nanomedicineAdvanced Drug Delivery Reviews, 2025
- Water-stable perovskite/metallic nanocomposites-based SERS aptasensor for detection of neuron-specific enolaseBiosensors and Bioelectronics, 2025
- Portable Aptasensor Based on Parallel Rolling Circle Amplification for Tumor‐Derived Exosomes Liquid BiopsyAdvanced Science, 2024
- Wearable Aptalyzer Integrates Microneedle and Electrochemical Sensing for In Vivo Monitoring of Glucose and Lactate in Live AnimalsAdvanced Materials, 2024
- Cancer biomarkers: Emerging trends and clinical implications for personalized treatmentCell, 2024
- An Aptamer‐Based Nanoflow Cytometry Method for the Molecular Detection and Classification of Ovarian Cancers through Profiling of Tumor Markers on Small Extracellular VesiclesAngewandte Chemie International Edition, 2023
- Lung Cancer Screening in Asia: An Expert Consensus ReportJournal of Thoracic Oncology, 2023
- Improving aptamer performance: key factors and strategiesMicrochimica Acta, 2023
- Isolation of PD‐L1 Extracellular Vesicle Subpopulations Using DNA Computation Mediated Microfluidic Tandem SeparationSmall Methods, 2023